Intravesical treatment of overactive bladder

Urology

Volumn 55, Issue 5 SUPPL., 2000, Pages 60-64

  Fowler, Clare J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BUPIVACAINE; CAPSAICIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; OXYBUTYNIN; RESINIFERATOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DITERPENE; MANDELIC ACID DERIVATIVE; NEUROTOXIN;

ARTICLE; DETRUSOR DYSSYNERGIA; HUMAN; PRIORITY JOURNAL; BLADDER DISEASE; DRUG EFFECT; INTRAVESICAL DRUG ADMINISTRATION; REVIEW; SENSORY NERVE CELL; URINE INCONTINENCE; BLADDER INSTABILITY; HYPERREFLEXIA; SHORT SURVEY;

ADMINISTRATION, INTRAVESICAL; ANESTHETICS, LOCAL; ATROPINE; CAPSAICIN; CHOLINERGIC ANTAGONISTS; DITERPENES; HUMANS; MANDELIC ACIDS; NEURONS, AFFERENT; NEUROTOXINS; URINARY BLADDER DISEASES; URINARY INCONTINENCE;

EID: 0034185210     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00498-7     Document Type: Article

References (29)

1. Mohler J. Relaxation of intestinal bladders by intravesical oxybutynin chloride. Neurourol Urodyn. 9:1990;179-187.
2. Brendler C., Radebaugh L., Mohler J. Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol. 141:1989;1350-1352.
3. Madersbacher H., Jilg G. Control of detrusor hyperreflexia by intravesical instillation of oxybutynin hydrochloride. Paraplegia. 29:1991;84-90.
4. Greenfield S., Fera M. The use of intravesical oxybutynin chloride in children with neurogenic bladder. J Urol. 146:1991;532-534.
5. Massad C., Kogan B., Trigo-Rocha F. The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol. 148:1992;595-597.
6. Glickman S., Tsokkos N., Shah P. Intravesical atropine suppression of detrusor hypercontractility in the neuropathic bladder. A preliminary study. Paraplegia. 33:1995;36-39.
7. Deaney C., Glickman S., Gluck T., et al. Intravesical atropine suppression of detrusor hyperreflexia in multiple sclerosis. J Neurol Neurosurg Psychiatry. 65:1998;957-958.
8. Higson R., Smith J., Hills W. Intravesical lignocaine and detrusor instability. Br J Urol. 51:1979;500-503.
9. McInerney P., Grant A., Chawla J., et al. The effect of intravesical Marcain instillation on hyperreflexic detrusor contractions. Paraplegia. 2:1992;127-130.
10. Reuther A., Aagaard J., Jensen K. Lignocaine test and detrusor instability. Br J Urol. 55:1983;493-494.
11. de Groat W., Kawatani T., Hisamitsu T., et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Sys. 30:1990;S71-S81.
12. Dixon J., Gilpin C. Presumptive sensory axons of the human urinary bladder. A fine ultrastructural study. J Anat. 151:1987;199-207.
13. Smet P., Moore K., Jonavicius J. Distribution and co-localization of calcitonin gene-related peptide, tachykinins and vasoactive intestinal polypeptide in normal and idiopathic unstable human urinary bladder. Lab Invest. 77:1997;37-49.
14. Fowler C.J., Jewkes D., McDonald W.I., et al. Intravesical capsaicin for neurogenic bladder dysfunction (letter). Lancet. 339:1992;1239.
15. Fowler C.J., Beck R.O., Gerrard S., et al. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry. 57:1994;169-173.
16. De Ridder D., Chandiramani V., Dasgupta P., et al. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia a dual centre study with long-term follow-up . J Urol. 158:1997;2087-2092.
17. Chandiramani V.A., Petersen T., Duthie G.S., et al. Urodynamic changes during therapeutic intravesical instillations of capsaicin. Br J Urol. 77:1996;792-797.
18. Dasgupta P., Fowler C.J., Stephen R. Electromotive drug administration (EMDA) of lidocaine to anesthetize the bladder before intravesical capsaicin. J Urol. 159:1998;1857-1861.
19. de Seze M., Wiart L., Joseph P., et al. Capsaicin and neurogenic detrusor hyperreflexia A double blind placebo-controlled study in 20 patients with spinal cord lesions . Neurourol Urodyn. 17:1998;513-523.
20. Wiart L., Joseph P., Petit H., et al. The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Spinal Cord. 36:1998;95-99.
21. Cruz F., Guimaraes M., Silva C., et al. Desensitization of bladder sensory fibres by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol. 157:1997;558-558.
22. Sedor J., Chancellor M., Rivas D. Intravesical capsaicin in neurologically impaired patients with detrusor hyperreflexia. J Urol. 155:(Suppl):1996;592A.
23. Geirsson G., Fall M., Sullivan L. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol. 154:1995;1825-1829.
24. Igawa Y., Komiyama I., Nishizawa S., et al. Intravesical capsaicin inhibits autonomic dysreflexia in patients with spinal cord injury. Neurourol Urodyn. 4:1996;374-376.
25. Dasgupta P, Chandiramani VA, Beckett A, et al: The effect of capsaicin on nerve densities in the human urinary bladder. Br J Urol (in press).
26. Hussain I.F., Fowler C.J., Landon D.N. Ultrastructural changes in the composition of lamina propria nerves following intravesical capsaicin therapy. Eur Urol. 35:(Suppl 2):1999;95A.
27. Craft R., Cohen S., Porreca F. Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain. 61:1995;317-323.
28. Cruz F., Guimaraes M., Silva C., et al. Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet. 350:1997;640-641.
29. Lazzeri M., Beneforti P., Turini D. Urodynamic effects of intravesical resiniferatoxin in humans preliminary results in stable and unstable detrusor . J Urol. 158:1997;2093-2096.